Simcere Pharmaceutical Group Ltd

Common Name
Simcere Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6,584
Ticker
2096
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Simcere Pharmaceutical Group Ltd. is a leading biopharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products. Its primary focus is on the...

Simcere Pharmaceutical Group Waste Data Preview

In 2023, Simcere Pharmaceutical Group conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Simcere Pharmaceutical Group’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Simcere Pharmaceutical Group generated a total of 4,049 metric tonnes of waste.

Of this amount, 46.84% of Simcere Pharmaceutical Group's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 53.16% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Simcere Pharmaceutical Group’s Hazardous vs Non-Hazardous Waste Over Time

20212022202301.5 k3 k4.5 k6 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Simcere Pharmaceutical Group reduced the environmental impact of its waste?

Since 2021, Simcere Pharmaceutical Group's total waste generation increased by 44.36%, including a 19.07% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.

Over the same period, Simcere Pharmaceutical Group reduced the hazardousness of its waste by 20.77%, with a further 12.78% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.

Overall, Simcere Pharmaceutical Group is generating more waste but has significantly reduced the share of hazardous materials, suggesting a partial decoupling of volume and toxicity that could reflect more responsible inputs or enhanced treatment.

Want Full Access to Simcere Pharmaceutical Group's Waste Management Dataset?
Sign Up